LAVAL, QUEBEC
Boehringer Ingelheim inaugurated the $36 million Global Centre of Excellence for Antiviral Drug Discovery in Laval, Quebec, in May of 2008. Supporting the discovery of treatments for serious infectious diseases including Hepatitis C and AIDS, the laboratory can accommodate 40 researchers. The project construction manager was Kingston Beyers of LaSalle, Quebec.
